PCR Array Technology in Biopsy Samples Identifies Up-Regulated mTOR Pathway Genes as Potential Rejection Biomarkers After Kidney Transplantation

Frontiers in Medicine

Diego Salmeron¹  Rafael Alfaro²  María Victoria Bernardo²  Anna Mrowiec²  Carmen Botella²  Manuel Muro²  Antonio Parrado²  María Rosa Moya-Quiles²  Jose Antonio Galián²  Alfredo Minguela²  Helios Martínez-Banaclocha²  Victor Jimenez-Coll²  Francisco Boix²  Isabel Legaz³  Santiago Llorente⁴  Jesús de la Peña-Moral⁵ 

[1] Departamento de Ciencias Sociosanitarias, Universidad de Murcia, Murcia, Spain;Centro de Investigación Biomédica en Red (CIBER) Epidemiología y Salud Pública (CIBERESP), Murcia, Spain;Instituto Murciano de Investigacion Biomédica-Arrixaca, Murcia, Spain;Department of Immunology, University Clinical Hospital Virgen de la Arrixaca-Biomedical Research Institute of Murcia (IMIB), Murcia, Spain;Department of Legal and Forensic Medicine, Faculty of Medicine, Biomedical Research Institute (IMIB), University of Murcia, Murcia, Spain;Department of Nephrology, University Clinical Hospital Virgen de la Arrixaca-Biomedical Research Institute of Murcia (IMIB), Murcia, Spain;Department of Pathology Services, University Clinical Hospital Virgen de la Arrixaca-Biomedical Research Institute of Murcia (IMIB), Murcia, Spain;

关键词: mTOR;    Gene expression;    medico-legal autopsy;    antibody-mediated rejection;    PCR array;   

DOI  :  10.3389/fmed.2021.547849

来源: Frontiers

【 授权许可】

CC BY